Affinity Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,002
| Closed | -$222K | – | 154 |
|
|
2024
Q1 | $222K | Sell |
8,002
-298
| -4% | -$8.27K | 0.05% | 138 |
|
|
2023
Q4 | $239K | Sell |
8,300
-15
| -0.2% | -$432 | 0.06% | 123 |
|
|
2023
Q3 | $276K | Sell |
8,315
-31
| -0.4% | -$1.03K | 0.08% | 104 |
|
|
2023
Q2 | $306K | Sell |
8,346
-175
| -2% | -$6.42K | 0.08% | 97 |
|
|
2023
Q1 | $348K | Sell |
8,521
-372
| -4% | -$15.2K | 0.11% | 86 |
|
|
2022
Q4 | $456K | Sell |
8,893
-65
| -0.7% | -$3.33K | 0.16% | 66 |
|
|
2022
Q3 | $392K | Buy |
8,958
+11
| +0.1% | +$481 | 0.14% | 72 |
|
|
2022
Q2 | $469K | Buy |
8,947
+120
| +1% | +$6.29K | 0.16% | 68 |
|
|
2022
Q1 | $457K | Buy |
8,827
+109
| +1% | +$5.64K | 0.14% | 68 |
|
|
2021
Q4 | $515K | Buy |
8,718
+3
| +0% | +$177 | 0.16% | 69 |
|
|
2021
Q3 | $375K | Sell |
8,715
-65
| -0.7% | -$2.8K | 0.13% | 82 |
|
|
2021
Q2 | $344K | Sell |
8,780
-1,100
| -11% | -$43.1K | 0.12% | 86 |
|
|
2021
Q1 | $358K | Sell |
9,880
-292
| -3% | -$10.6K | 0.13% | 82 |
|
|
2020
Q4 | $374K | Sell |
10,172
-523
| -5% | -$19.2K | 0.15% | 74 |
|
|
2020
Q3 | $372K | Sell |
10,695
-887
| -8% | -$30.9K | 0.21% | 68 |
|
|
2020
Q2 | $359K | Sell |
11,582
-122
| -1% | -$3.78K | 0.23% | 65 |
|
|
2020
Q1 | $410K | Sell |
11,704
-143
| -1% | -$5.01K | 0.3% | 56 |
|
|
2019
Q4 | $440K | Buy |
+11,847
| New | +$440K | 0.29% | 54 |
|